Investors Archives

Applied DNA Reschedules Investor Update Call in Observance of the National Day of Mourning in Recognition of the Passing of Former President Jimmy Carter

STONY BROOK, N.Y. January 8, 2025 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in polymerase chain reaction (PCR)-based technologies, today announced that it has rescheduled its Investor Update call to Thursday, February 13, 2025, to coincide with the release of its first quarter fiscal 2025 financial results. [...]

heather2025-01-08T16:22:58-05:00Categories: Corporate/Financial News, Investors, Press Release|

APDN Announces Pricing of $6.5 Million Registered Direct Offering and Concurrent Private Placement

STONY BROOK, N.Y. October 30, 2024 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in PCR-based DNA technologies, today announced the pricing of a registered direct offering and concurrent private placement with gross proceeds to the Company expected to be approximately $6.5 million before deducting placement agent fees [...]

heather2024-10-30T08:53:26-04:00Categories: Investors, Press Release, Uncategorized|

Applied DNA to Participate in the 2024 Maxim Healthcare Virtual Summit on Wednesday, October 16

STONY BROOK, N.Y., October 15, 2024 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA”), a leader in PCR-based DNA technologies, today announced that Dr. James A. Hayward, president and chief executive officer, will participate in a fireside chat at the 2024 Maxim Healthcare Virtual Summit. Maxim Group LLC is presenting the virtual summit [...]

heather2024-10-15T10:22:37-04:00Categories: Corporate/Financial News, Investors, Press Release|

Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement

STONY BROOK, N.Y., September 18, 2024 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA), a leader in PCR-based DNA technologies, today announced that on September 17, 2024, it received a notification letter (the “Notification Letter”) from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”), informing the Company that it has regained compliance with [...]

heather2024-09-18T06:45:46-04:00Categories: Investors, Press Release|

APDN Announces Third Quarter Fiscal Year 2024 Financial Results

STONY BROOK, N.Y. – August 8, 2024 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in PCR-based DNA technologies, today announced consolidated financial results for its third fiscal quarter ended June 30, 2024. The Company’s Form 10-Q can be viewed at https://investors.adnas.com/sec-filings/. Third Quarter Operational Highlights [...]

heather2024-08-08T16:34:20-04:00Categories: Investors, Press Release|

APDN to Report FQ3’24 Advisory: Thursday, August 8, 2024

STONY BROOK, N.Y. – August 7, 2024 – Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in polymerase chain reaction (PCR)-based technologies, today announced that it will release its third quarter fiscal 2024 financial results after market close on Thursday, August 8, 2024. In conjunction with this announcement, Applied [...]

heather2024-08-07T07:51:38-04:00Categories: Investors, Press Release|

APDN Announces Pricing of $12 Million Public Offering

STONY BROOK, N.Y., May 28, 2024 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in PCR-based DNA technologies, today announced the pricing of a public offering with gross proceeds to the Company expected to be approximately $12.0 million, before deducting placement agent fees and other estimated expenses payable [...]

heather2024-05-28T12:27:55-04:00Categories: Investors, Press Release|

APDN Announces Second Quarter Fiscal Year 2024 Financial Results

STONY BROOK, N.Y. May 10, 2024 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in PCR-based DNA technologies, today announced consolidated financial results for its second fiscal quarter ended March 31, 2024. The Company’s Form 10-Q can be viewed at https://investors.adnas.com/sec-filings/. The Company will not host a financial [...]

heather2024-09-23T11:36:28-04:00Categories: Investors, Press Release|

APDN Regains Compliance with Nasdaq Minimum Bid Price Requirement

STONY BROOK, N.Y., - May 10, 2024 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA), a leader in PCR-based DNA technologies, today announced that on May 9, 2024, it received a notification letter (the “Notification Letter”) from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”), informing the Company that it has regained [...]

heather2024-05-09T18:43:06-04:00Categories: Investors, Press Release|